A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST (immune Response Evaluation Criteria in Solid Tumors) in oncological patients undergoing immune-based treatment. Utilizing mint Lesion™ for software-assisted assessment, the study found that software-assisted assessments resulted in shorter reading times, lower error rates, and higher inter-reader agreement compared to manual assessments. The researchers thus concluded that software-assisted iRECIST assessments are preferable over manual approaches for optimal oncological response evaluation.
Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study
Related Resources
Related Resources
A look ahead with mint Lesion 3.3
Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint Lesion™ which was completed during recent weeks.…
New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany
Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen,…
Mrs. Kelie Luby joins Mint Medical's team
Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming…